Clinical Trial Update: The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating atezolizumab, bevacizumab, and memantine in hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Memantine (memantine)

Snippet

Sponsor: Inova Health Care Services | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING